114420-06-3Relevant articles and documents
Preparation method of antitumor drug gemcitabine hydrochloride
-
, (2020/12/31)
The invention discloses a preparation method of an antitumor drug gemcitabine hydrochloride. The preparation method specifically comprises the following processes: (1) preparing an antitumor drug gemcitabine hydrochloride intermediate: Step 1, synthesis of T1; Step2, synthesis of T2; Step3, synthesis of T3; Step4, synthesis of T4; Step5, synthesis of T5; and Step6, synthesis of T6; and (2) preparing gemcitabine hydrochloride from the gemcitabine hydrochloride intermediate: Step7, firstly reducing T6 with lithium tri (tert-butoxy) aluminum hydride, and then acylating with paratoluensulfonyl chloride to prepare T7, wherein T7 is 2-deoxy-2, 2-difluoro-D-ribofuranose-3, 5-dibenzoate; and Step8, reacting T7 with cytosine under the action of a catalyst to generate T8, wherein T8 is 2'-deoxy-2',2'-difluorocytidine-D-ribofuranose-3',5'-dibenzoate. The preparation method of the antitumor drug gemcitabine hydrochloride has the advantages of low production cost, favorability for industrial production and small environmental pollution.
Difluoro antivirals and intermediate therefor
-
, (2008/06/13)
A 2,2-difluoro-2-desoxycarbohydrate is used to prepare antiviral nucleosides.